{"id":{"repo_id":"wfu","oai_identifier":"oai:wakespace.lib.wfu.edu:10339/82186"},"canonical_url":"https://search.dev.ndltd.org/etd/wfu/oai:wakespace.lib.wfu.edu:10339/82186","repository":{"repo_id":"wfu","name":"Wake Forest University","base_url":"https://wakespace.lib.wfu.edu/oai/request"},"display":{"title":"STUDIES IN THE DEVELOPMENT OF A XENOGRAFT-DERIVED BONE SCAFFOLD","abstract":"Bone grafts are used in nearly one half of all musculoskeletal surgeries and represent an enormous health care expenditure. Tissue-engineered bone graft substitutes have garnered considerable attention to alleviate the risk of bone graft harvest and potential for disease transmission. Xenografts sources are an attractive alternative because of their relatively unlimited supply from a pool of healthy donors but have historically been limited by the alpha-Gal epitope which may lead to immune system rejection of the graft. In the presented dissertation, we derive a bone scaffold from the cancellous bone of porcine (pig) femurs using a novel decellularization and chemical oxidation protocol. In the following chapters we discuss the development and characterization of this bone scaffold. The presented results show the decellularization protocol is able to efficiency remove porcine cellular material to yield a scaffold that is devoid of cellular material and has similar biology and biomechanical properties to the starting cancellous bone. In vitro studies show the scaffold is biocompatible and free of contaminating pathogens supporting its consideration for further investigation. Molecular studies demonstrate that a substantial proportion of the alpha-Gal epitope is removed from source bone with the decellularization protocol. Lastly we show that the scaffold possesses some degree of osteoinductive potential that may direct undifferentiated cells towards an osteoblastic lineage and promote bone regeneration. A xenograft-derived bone scaffold has the potential to alleviate the patient morbidity imparted by autograft bone harvest, eliminate the risk of disease transmission associated with allograft bone transplantation, and satisfy the currently unsatisfied demand for bone graft products in the United States.","abstract_html":"Bone grafts are used in nearly one half of all musculoskeletal surgeries and represent an enormous health care expenditure. Tissue-engineered bone graft substitutes have garnered considerable attention to alleviate the risk of bone graft harvest and potential for disease transmission. Xenografts sources are an attractive alternative because of their relatively unlimited supply from a pool of healthy donors but have historically been limited by the alpha-Gal epitope which may lead to immune system rejection of the graft. In the presented dissertation, we derive a bone scaffold from the cancellous bone of porcine (pig) femurs using a novel decellularization and chemical oxidation protocol. In the following chapters we discuss the development and characterization of this bone scaffold. The presented results show the decellularization protocol is able to efficiency remove porcine cellular material to yield a scaffold that is devoid of cellular material and has similar biology and biomechanical properties to the starting cancellous bone. In vitro studies show the scaffold is biocompatible and free of contaminating pathogens supporting its consideration for further investigation. Molecular studies demonstrate that a substantial proportion of the alpha-Gal epitope is removed from source bone with the decellularization protocol. Lastly we show that the scaffold possesses some degree of osteoinductive potential that may direct undifferentiated cells towards an osteoblastic lineage and promote bone regeneration. A xenograft-derived bone scaffold has the potential to alleviate the patient morbidity imparted by autograft bone harvest, eliminate the risk of disease transmission associated with allograft bone transplantation, and satisfy the currently unsatisfied demand for bone graft products in the United States.","abstract_has_math":false,"creators":["Bracey, Daniel Nicholas"],"institution":"Wake Forest University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2017,"date_issued":"2017","date_published":"2017","updated_at":"2026-07-27T22:02:11Z","subjects":["Bone Scaffold"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/10339/82186","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Bracey, Daniel Nicholas"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2017-06-15T08:35:51Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2019-06-14T08:30:13Z"]},{"key":"dc:date.issued","label":"Date","values":["2017"]},{"key":"dc:publisher","label":"Institution","values":["Wake Forest University"]},{"key":"dc:type","label":"Dc Type","values":["Dissertation"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Bone Scaffold"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/10339/82186"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Bone grafts are used in nearly one half of all musculoskeletal surgeries and represent an enormous health care expenditure. Tissue-engineered bone graft substitutes have garnered considerable attention to alleviate the risk of bone graft harvest and potential for disease transmission. Xenografts sources are an attractive alternative because of their relatively unlimited supply from a pool of healthy donors but have historically been limited by the alpha-Gal epitope which may lead to immune system rejection of the graft. In the presented dissertation, we derive a bone scaffold from the cancellous bone of porcine (pig) femurs using a novel decellularization and chemical oxidation protocol. In the following chapters we discuss the development and characterization of this bone scaffold. The presented results show the decellularization protocol is able to efficiency remove porcine cellular material to yield a scaffold that is devoid of cellular material and has similar biology and biomechanical properties to the starting cancellous bone. In vitro studies show the scaffold is biocompatible and free of contaminating pathogens supporting its consideration for further investigation. Molecular studies demonstrate that a substantial proportion of the alpha-Gal epitope is removed from source bone with the decellularization protocol. Lastly we show that the scaffold possesses some degree of osteoinductive potential that may direct undifferentiated cells towards an osteoblastic lineage and promote bone regeneration. A xenograft-derived bone scaffold has the potential to alleviate the patient morbidity imparted by autograft bone harvest, eliminate the risk of disease transmission associated with allograft bone transplantation, and satisfy the currently unsatisfied demand for bone graft products in the United States."]},{"key":"dc:title","label":"Title","values":["STUDIES IN THE DEVELOPMENT OF A XENOGRAFT-DERIVED BONE SCAFFOLD"]}]}],"canonical_facts":{"dc:creator":["Bracey, Daniel Nicholas"],"dc:date.accessioned":["2017-06-15T08:35:51Z"],"dc:date.available":["2019-06-14T08:30:13Z"],"dc:date.issued":["2017"],"dc:description.abstract":["Bone grafts are used in nearly one half of all musculoskeletal surgeries and represent an enormous health care expenditure. Tissue-engineered bone graft substitutes have garnered considerable attention to alleviate the risk of bone graft harvest and potential for disease transmission. Xenografts sources are an attractive alternative because of their relatively unlimited supply from a pool of healthy donors but have historically been limited by the alpha-Gal epitope which may lead to immune system rejection of the graft. In the presented dissertation, we derive a bone scaffold from the cancellous bone of porcine (pig) femurs using a novel decellularization and chemical oxidation protocol. In the following chapters we discuss the development and characterization of this bone scaffold. The presented results show the decellularization protocol is able to efficiency remove porcine cellular material to yield a scaffold that is devoid of cellular material and has similar biology and biomechanical properties to the starting cancellous bone. In vitro studies show the scaffold is biocompatible and free of contaminating pathogens supporting its consideration for further investigation. Molecular studies demonstrate that a substantial proportion of the alpha-Gal epitope is removed from source bone with the decellularization protocol. Lastly we show that the scaffold possesses some degree of osteoinductive potential that may direct undifferentiated cells towards an osteoblastic lineage and promote bone regeneration. A xenograft-derived bone scaffold has the potential to alleviate the patient morbidity imparted by autograft bone harvest, eliminate the risk of disease transmission associated with allograft bone transplantation, and satisfy the currently unsatisfied demand for bone graft products in the United States."],"dc:identifier.uri":["http://hdl.handle.net/10339/82186"],"dc:language.iso":["en"],"dc:publisher":["Wake Forest University"],"dc:subject":["Bone Scaffold"],"dc:title":["STUDIES IN THE DEVELOPMENT OF A XENOGRAFT-DERIVED BONE SCAFFOLD"],"dc:type":["Dissertation"]},"updated_at":"2026-07-27T22:02:11Z"}